Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

PURPOSE: Paclitaxel-based chemotherapy continues to be an integral component of breast cancer treatment. Prolonged use of paclitaxel may result in repeated doses of premedications that can have unwanted side effects. Infusion hypersensitivity reactions occurring beyond the second dose of paclitaxel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Support Care Cancer
Main Authors: Berger, Michael J., Vargo, Craig, Vincent, Mary, Shaver, Katy, Phillips, Gary, Layman, Rachel, Macrae, Erin, Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Wesolowski, Robert, Shapiro, Charles L., Lustberg, Maryam B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4804339/
https://ncbi.nlm.nih.gov/pubmed/25519756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2556-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados